The clinical significance of molecular response in indolent follicular lymphomas

Blood

Volumn 91, Issue 8, 1998, Pages 2955-2960

  López Guillermo, Armando ^a   Cabanillas, Fernando ^a,b   McLaughlin, Peter ^a   Smith, Terry ^a   Hagemeister, Fredrick ^a   Rodríguez, María A ^a   Romaguera, Jorge E ^a   Younes, Anas ^a   Sarris, Andreas H ^a   Preti, H Alejandro ^a   Pugh, William ^a   Lee, Ming Seng ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 2642590949     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.2955.2955_2955_2960     Document Type: Article

References (30)

1. Lister TA: The management of follicular lymphoma. Ann Oncol 2:131, 1991
2. Romaguera JE, McLaughlin P, North L, Dixon D, Silvermintz KB, Garnsey LA, Velasquez WS, Hagemeister FB, Cabanillas F: Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. J Clin Oncol 9:762, 1991
3. Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RR, Theologides A: Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 307:1231, 1982
4. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cell with the t(14;18) chromosome translocation. Science 226:1097, 1984
5. Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ: Expression of bcl-2 and bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 80:1512, 1987
6. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
7. Tsujimoto Y, Cossman J, Jaffe E, Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440, 1986
8. Cleary ML, Galili N, Sklar J: Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315, 1986
9. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA: Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237:175, 1987
10. Stetler-Stevenson M, Raffeld M, Cohen P, Cossman J: Detection of occult follicular lymphoma by specific DNA amplification. Blood 72:1822, 1988
11. Price CGA, Meerabux J, Murtagh S, Cotter FE, Rohatiner AZS, Young BD. Lister TA: The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 9:1527, 1991
12. Finke J, Slanina J, Lange W, Dolken G: Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 11:1668, 1993
13. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
14. Lambrechts AC, Hupkes PE, Dorssers LCJ, van't Veer MB: Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 12:1541, 1994
15. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Specter N, Rabinowe SN, Grossbard ML, Ritz J, Nadler LM: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993
16. Hardingham JE, Kotasek D, Sage RE, Gooley LT, Mi JX, Dobrovic A, Norman JE, Bolton AE, Dale BM: Significance of molecular marker-positive cells after autologous peripheral-blood stemcell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 13: 1073, 1995
17. McLaughlin P, Hagemeister FB, Swan F, Cabanillas F, Romaguera J, Rodríguez MA, Lee MS, Pate O, Sarris A, Yones A: Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. Ann Oncol 5:S73, 1994 (suppl 2)
18. Saiki RK, Gelfand DH, Stoffel S, Scharf S, Higuchi R, Horn G, Mulis K, Ehrlich H: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487, 1988
19. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
20. 2/E in the log-rank test for survival data or tumour incidence data. Biometrics 29:759, 1973
21. Anderson JR, Cain KC, Gelber RD: Analysis of survival by tumor response. J Clin Oncol 1:710, 1983
22. Cox DR: Regression models and life tables. J R Stat Soc 34:187, 1972
23. Yuan R, Dowling P, Zucca E, Diggelmann H, Cavalli F: Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: Concordant results of peripheral blood and bone marrow analysis at diagnosis. Br J Cancer 67:922, 1993
24. Berinstein NL, Reis MD, Ngan BY, Sawka CA, Jamal HH, Kuzniar B: Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early stage and advanced stage follicular lymphoma. J Clin Oncol 11:1344, 1993
25. Berinstein NL, Jamal HH, Kuzniar B, Klock RJ, Reis MD: Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment. Leukemia 7: 113, 1993
26. Gribben JG, Neuberg D, Barber M, Moore J, Peseu KW, Freedman AS, Nadler LM: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994
27. Gribben JG, Nadler LM: Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction, in de Vita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology 1994. Philadelphia, PA, Lippincott, 1994, p 117
28. Dolken G, Illerhaus G, Hirt C, Mertelsmann R: BCL-2/Jh rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14:1333, 1996
29. Limpens J. Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJB, Schuuring E, Kluin PM: Lymphoma-associated translocation t(14;18) in blood B-cells of normal individuals. Blood 85:2528, 1995
30. Liu Y, Hernandez AM, Shibata D, Cortopassi GA: Bcl-2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91:8910, 1994